Group items tagged

"ChatGPT 4o is the newest flagship model on OpenAI. It provides GPT 4-level intelligence but is much faster and improves on its capabilities across text, voice, and vision. ChatGPT 4o can be used for free on the ChatGPT4o.one website.  ChatGPT 4o Free is an innovative AI-powered chatbot that is changing the way we interact with artificial intelligence. Utilizing advanced technology and neural networks, Chat GPT 4o can generate responses that closely mimic human conversation, creating a more natural and engaging dialogue experience."

"Generate Insight with AI and Knowledge Graphs Get an overview of any discourse, reveal the blind spots, enhance your perspective."

"Decentralized AI The first peer-to-peer network for general purpose AI, powered by MOR "

Researchers at Stanford University in the US have developed new sensors that can be adhered to the skin for wireless monitoring of health. The sensors are designed to identify the physiological signals that the skin emanates, such as pulse. These readings will be wirelessly transmitted to a receiver clipped onto clothing. The sensor and receiver system has been named BodyNet.

UK-based online therapy provider Ieso Digital Health has applied deep learning to provide new insights into which aspects of psychotherapy are the most effective.

A research team led by the University of Strathclyde in the UK has developed an artificial intelligence (AI)-based blood test for the diagnosis of brain cancer.

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.

Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.

Patient enrolment has begun on Biotronik's study of its new Acticor and Rivacor range of cardiac rhythm management (CRM) devices.

Researchers at the University of Washington have developed a new contactless artificial intelligence (AI) tool to monitor at-risk patients for cardiac arrest, even when they're asleep.

3D printing solutions provider Materialise has obtained clearance for its Mimics Enlight cardiovascular planning software suite from the US Food and Drug Administration (FDA).